Completed PHASE1 INTERVENTIONAL 1-arm NCT03004768

Pharmacokinetics and Metabolism of [14C]BMS-986165 in Healthy Male Participants

Sponsor: Bristol-Myers Squibb

Conditions Psoriasis

Interventions BMS-986165

Updated 7 times since 2017 Last updated: Feb 8, 2018 Started: Jan 26, 2017 Primary completion: Feb 27, 2017 Completion: Feb 27, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Psoriasis, this trial is completed. The trial is conducted by Bristol-Myers Squibb and has accumulated 7 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Mar 2018 — Jun 2018 [monthly]

Completed PHASE1

Status: Not Yet Recruiting → Completed

▶ Show 2 earlier versions

Feb 2017 — Mar 2018 [monthly]

Not Yet Recruiting PHASE1
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bristol-Myers Squibb
Covance

Data source: Bristol-Myers Squibb

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madison, United States